Simply tracking calories and injection dates may overlook key factors that affect body composition
The management of diabetic kidney disease (DKD) secondary to type 2 diabetes now centres on four pillars of treatment: renin-angiotensin system blockade (with ACE inhibitors or angiotensin receptor blockers), sodium-glucose cotransporter-2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists and glucagon-like peptide-1 receptor agonists
For mild cases or other GI conditions, starting at even lower doses (0.125 mg weekly via precise syringe measurement from a 2.5mg/mL vial) and titrating over eight to twelve weeks per level can improve tolerability
[Lipoprotein (a): influence on cardiovascular manifestation.]
Who Should Not Use Sermorelin Like any growth hormone-stimulating therapy, Sermorelin is contraindicated in patients with active malignancy or a personal history of certain cancers, because anything that drives GH/IGF-1 production has theoretical risk in those settings
If an athlete is prescribed a GLP-1 by a doctor to manage Type 2 diabetes, its important to be aware of the potential for Relative Energy Deficiency in Sport (REDs) due to under-fueling, so your athlete should be working with their doctor and other professionals to determine appropriate fueling and training while using the medication.